Celcuity Inc. Stock 12‑Month Price Target Cut to $160.64, Implies 85% Upside
Analyst estimates for Celcuity Inc. show the average 12-month price target was cut from $163.55 to $160.64, with a range of $140 to $178 per share, according to 11 analysts. Based on the Aug. 13 closing price, the target suggests about 85% upside. The consensus rating remains “Buy” with 12 Buys, 0 Holds, and 0 Sells.
How this was made

The 30-second read
Why it matters
This is a sentiment/expectations update rather than a new fundamental disclosure. The implied upside remains high, but the average target is slightly lower.
Market read
Traders may treat this as a mild sentiment headwind, but without new operating or clinical information it is unlikely to drive a major repricing by itself.
What to watch
The article does not state which analysts changed targets, whether any thesis was revised, or whether the Aug. 13 close moved materially; those details could matter more than the average target level.
Background
The article summarizes FactSet-derived analyst consensus for Celcuity’s 12-month price target and rating distribution.
Ticker impact
Celcuity’s consensus 12-month price target was cut from $163.55 to $160.64, with analyst forecasts spanning $140 to $178.
Likely limited near-term impact unless the broader analyst note set includes thesis changes; this reads as a target adjustment rather than a new fundamental catalyst.
The only disclosed change is the average price target level and the implied upside, with no new company-specific operating, regulatory, or clinical datapoint.
Market effects
Minimal, since the piece provides no sector-wide regulatory, trial, or reimbursement update.
None indicated.
None indicated.
Counterpoint
A target cut can reflect reduced confidence in near-term catalysts even if the rating stays Buy; traders may fade the implied upside if the underlying thesis deteriorated off-screen.
Key entities
- companyCelcuity Inc.
Subject of the article, with an average 12-month price target cut to $160.64 and consensus rating still Buy.


